Skip to main content

Market Overview

UPDATE: Monness Crespi Hardt Downgrades Leggett & Platt to Neutral on March Quarter Preview

Share:

In a report published Friday, Monness Crespi Hardt analyst Herb Hardt downgraded the rating on Leggett & Platt (NYSE: LEG) from Buy to Neutral.

In the report, Hardt noted, “The March Quarter should be in line with MCH and consensus EPS estimates of $0.38 per share versus $0.30 per share last year on a 4-5% increase in sales. The results of the restructuring efforts over the past few years were apparent in the December Quarter when operating earnings were $0.32 per share versus a $0.22 per share comparison. Revenues in that December quarter were essentially flat, but margins improved in all divisions. At 21x the $1.65 per share estimate for this year and 16x the $2.00 per share estimate for 2014, the stock is considered fairly valued at this point, and is therefore being downgraded to a neutral rating. On a long term basis LEG is still an excellent holding, but new purchases should be made on price weakness.”

Leggett & Platt closed on Thursday at $31.93.

Latest Ratings for LEG

DateFirmActionFromTo
Feb 2022Raymond JamesMaintainsOutperform
Nov 2021Raymond JamesMaintainsOutperform
May 2021Raymond JamesMaintainsOutperform

View More Analyst Ratings for LEG

View the Latest Analyst Ratings

 

Related Articles (LEG)

View Comments and Join the Discussion!

Posted-In: Monness Crespi HardtAnalyst Color Downgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com